Eurasia Consulting Investment Company
Strategic Intelligencefor Eurasian Decisions
From Hong Kong, ECIC connects policy research, investment insight and practical strategy across Eurasia.
Regional field notes
Eurasia in Motion
About ECIC
Institutional Overview
Founded in Hong Kong in 2022, ECIC combines forward-looking research, exclusive insight and high-level dialogue to provide governments, international organisations and enterprises with forward-looking policy solutions for geopolitical, policy and investment decisions.
Capabilities
Advisory Services
Four integrated practices connect research, risk analysis and practical decision support.
Corporate Custom Advisory
Geopolitical risk, M&A strategy and crisis communications for organisations operating across Eurasia.
Insight Analysis and Information Integration
Exclusive reports and real-time risk monitoring based on first-hand information and trusted networks.
Eurasian perspective
Regional Perspective
A connected view of the markets and policy environments shaping Eurasian decisions.
Europe
Central Asia
Greater Eurasia
Hong Kong
Latest news
News Centre
Verified original-language reporting and research on the policy, market and investment developments shaping Eurasian decisions.
View all newsEurope’s Overseas Countries and Territories as Geopolitical Assets
The British Indian Ocean Territory , also known as the Chagos Islands, was separated from Mauritius in 1965 to become fully administered by the British government. Meanwhile, a British-U.S. lease agreement covers the use and maintenance of the Diego Garcia air and naval base, an important asset in…
Ahead of the Deal: How the United States Can Build an Energy Project Pipeline in Emerging Markets
But long before qualifying for serious consideration by the DFC or other traditional development or commercial financiers, an energy project must achieve a large number of costly and time-consuming milestones, including completing project design; conducting feasibility studies and environmental…
Caught in the Middle: Chinese Biotech Firms’ Divergent Responses to U.S. Sanctions
The blinding spotlight on artificial intelligence has obscured the intensifying U.S.-China competition in biotech, particularly as China is racing to close the gap on research and development, innovation, and commercialization. Much like AI, biotech has become securitized, and the U.S. government…